United Therapeutics | UTHR - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Amarin USD 179.64M 14.82M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Baxter International USD 3.69B 723M 2026-03
Bayer EUR 33.46B 875M 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 300.36M 451K 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Insmed USD 361.01M 107.87M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
J&J USD 57.72B 3.59B 2026-03
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Moderna USD 2.4B 408M 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 34.35B 2.64B 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03